Wacker and Pantherna intensify collaboration in the development and production of mRNA biopharmaceuticals
Wacker Biotech is a CDMO for the GMP-compliant production of active ingredients for the pharmaceutical industry
Wacker Biotech is a CDMO for the GMP-compliant production of active ingredients for the pharmaceutical industry
Company is investing more than €100 million in the expansion of the Halle site
Subscribe To Our Newsletter & Stay Updated